Replies to post #173742 on Biotech Values

[ciotera]

Re: Sovaldi source of business

Interesting- I've been hearing about a lot of off-label simeprevir+sofosbuvir use, but it's not confirmed by GILD. Of course, they may not be completely open about this in a public release. Will be interesting to see how Olysio has done.